BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced multiple ...
New data demonstrate the potential of the Canopy Remote Therapeutic Monitoring (RTM) Platform to improve patient care by reducing hospitalizations and increasing time on treatment. Impact of remote ...
Hosted on MSN
Master the art of clinical case presentations
Presenting a patient case is more than reading notes aloud—it’s a curated, concise story that informs and persuades your clinical team. Mastering oral case presentations means knowing what to include, ...
A new study reveals that many oral cancers are no longer driven by traditional risk factors like smoking or Human papillomavirus infection.
TRIANA Biomedicines Announces Oral Presentation of TRI-611 and Additional Poster Presentations at the American Association for Cancer Research Annual Meeting 2026 TRIANA Biomedicines, Inc. (TRIANA), a ...
Oral squamous cell carcinoma (OSCC) remains a significant global health challenge, accounting for over 90% of oral malignancies. According to the International Agency for Research on Cancer (IARC), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results